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Abstract/Synopsis

Insulin resistance together with β-cell dysfunction leads to the appearance and gradual progression of type 2 diabetes. Type 2 diabetes, which accounts for almost 90% of the total diabetic population, stems from decreased responsiveness of the body to insulin, accompanied by the failure of pancreatic β-cells to secrete insulin to counteract this insulin-resistant state. Obesity-induced insulin resistance is thereby characterized by a loss of insulin sensitivity mediated by factors released from adipocytes, mainly free fatty acids and proteins, termed adipocytokines, which act to control various metabolic functions with well-described physiological effects. One such adipocytokine is tumour necrosis factor-α (TNFα), which has been identified as a significant contributor to insulin resistance, and its levels have been reported to be increased significantly in obese diabetic individuals and in several animal models of obesity. TNFα is believed to abrogate insulin action in target tissues, yet, the details of its role in hepatic gluconeogenesis in the insulin resistant state and the complex underlying mechanisms involved are not well studied. 
We have demonstrated an overall detailed analysis of the action of TNFα in HepG2 cells by encompassing the altered gene expression profile; the different GO functional terms these altered genes categories in and the consequent predicted signatures of conserved transcription factor binding sites in these sets of genes. Our results provide information towards identification of the underlying genes and transcription factors that determine among other significant liver phenotypes, hepatic steatosis and fatty liver that are critically associated with Diabetes. These results, add-on to the current knowledge of diabetic mechanisms and indicates that TNFα is one of the major contribution for cholesterol accumulation in the liver. Further we have demonstrated the role of TNFα in the regulation of gluconeogenesis and determined the underlying molecular mechanisms. Our results indicate that transcription factor, Foxa2, is responsible for the attenuating effect of TNFα on insulin action on PEPCK expression and glucose production in HepG2 cells. 

Although there are several reports of miRNAs playing important role in pathogenesis of many diseases, there role in the pathogenesis of diabetes is not completely understood. Therefore we studied the status of miRNAs in the diabetic db/db mice liver by microarray analysis and found that miR-29a levels are one of the most significantly elevated. Our finding reveals that miR-29a inhibits the PI3Kp85α proteins levels and through the PI3K-Akt pathway counteracts insulin inhibition of PEPCK gene expression. This presents a novel mode of regulation at this important point of metabolism. 



